Micro Cap Innovation Screener

Screening 235 names from $50M to $2B for patent activity, cash runway, revenue growth, and management quality. Includes the discovery cohort: main-universe stocks too young for a 200-week average, screened here until they earn one. 155 passed, 30 auto-rejected. Data as of 2026-11-14 13:59.

Read the 7-step methodology →
155
Passed Screening
30
Red Flag Rejected
-
Score 8+
-
With Patents
TickerScorePatentsRunwayRev GrowthMkt CapFCF%GM%D/EInsider %Tag
SGHT Sight Sciences, Inc.11/121755mo+25.2%$601.9M-0.4888635.2%Medical Devices
Score Breakdown
Patents: 3/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $88.4M
Cash: $77.4M
FCF: $-2.2M
ROE: -50.1% • D/E: 86%
Profit Margin: -32.1%
Quality
FCF insufficient_data
Patents (17)
• Controller for dry eye treatment systems
• Devices and methods for intraocular tissue manipulation
• Ocular delivery systems and methods
+2 more — view all
KIDS OrthoPediatrics Corp.11/1213CF++18.6%$844.7M1.2743330.2%Medical Devices
Score Breakdown
Patents: 3/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $264.1M
Cash: $44.2M
FCF: $9.9M
ROE: -9.8% • D/E: 33%
Profit Margin: -12.8%
Quality
FCF+ Low Debt FCF insufficient_data
Patents (13)
• Segmental tensioning of spinal tethers
• Multiple track system for positioning of bone segments
• Bone anchors with cord retention features
+2 more — view all
HYLN Hyliion Holdings Corp.10/122316mo+881.8%$441.9M-7.68530.1%Electrical Equipment
Score Breakdown
Patents: 3/3 • Runway: 1/3 • Revenue: 3/3 • Mgmt: 3/3
Financials
Revenue: $15.9M
Cash: $54.6M
FCF: $-33.5M
ROE: -27.4% • D/E: 5%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
Patents (23)
• Trailer-based energy capture and management
• Engine apparatus and method for operation
• Drive train configurations for a vehicle with multiple reversible engines
+2 more — view all
ANGO AngioDynamics, Inc.10/1228CF++6.9%$499.2M4.355622.1%Medical Devices
Score Breakdown
Patents: 3/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $325.4M
Cash: $34.0M
FCF: $21.3M
ROE: -19.2% • D/E: 6%
Profit Margin: -10.1%
Quality
FCF+ Low Debt FCF insufficient_data
Patents (28)
• Multiple treatment zone ablation probe
• System and method for synchronizing energy delivery to the cardiac rhythm
• Systems and methods for removing undesirable material within a circulatory system
+2 more — view all
RNA Atrium Therapeutics, Inc.10/122135mo+24.2%$162.0M-37.3-14012.1%Biotech
Score Breakdown
Patents: 3/3 • Runway: 2/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $38.8M
Cash: $232.1M
FCF: $-60.4M
ROE: -95.0% • D/E: 0%
Profit Margin: -180.9%
Quality
Low Debt FCF insufficient_data
Patents (21)
• Compositions and methods for treating ornithine transcarbamylase deficiency
• Molecules and agents for treating hepatitis B virus
• Coronavirus vaccine compositions and methods
+2 more — view all
FHTX Foghorn Therapeutics Inc.10/121322mo+924.7%$124.1M-21.231-56.4%Biotech
Score Breakdown
Patents: 3/3 • Runway: 1/3 • Revenue: 3/3 • Mgmt: 3/3
Financials
Revenue: $112.1M
Cash: $156.2M
FCF: $-26.4M
ROE: N/A • D/E: N/A
Profit Margin: 8.4%
Quality
FCF insufficient_data
Patents (13)
• Compounds and uses thereof
• Compounds and uses thereof
• BRD9 degraders and uses thereof
+2 more — view all
SMRT SmartRent, Inc.10/124CF++14.8%$301.8M2.740211.2%Application Software
Score Breakdown
Patents: 2/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $156.6M
Cash: $89.2M
FCF: $8.2M
ROE: -7.6% • D/E: 2%
Profit Margin: -11.0%
Quality
FCF+ Low Debt FCF insufficient_data
Patents (4)
• Thermostat
• Thermostat
• Thermostat
+1 more — view all
CTKB Cytek Biosciences, Inc.10/1211466mo+1.8%$763.8M1.153819.1%Medical Devices
Score Breakdown
Patents: 3/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $207.6M
Cash: $255.9M
FCF: $8.6M
ROE: -23.2% • D/E: 8%
Profit Margin: -39.1%
Quality
FCF+ Low Debt FCF insufficient_data
Patents (11)
• Cell sorter with pivotal scuppers
• Smart flow cytometers with self monitoring fluidics
• Methods of forming multi-color fluorescence-based flow cytometry panel
+2 more — view all
EDIT Editas Medicine, Inc.9/122321mo+37.4%$334.9M-10.2-731624.7%Biotech
Score Breakdown
Patents: 3/3 • Runway: 1/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $49.8M
Cash: $190.2M
FCF: $-34.0M
ROE: -147.4% • D/E: 16%
Profit Margin: -145.0%
Quality
Low Debt FCF insufficient_data
Patents (23)
• Systems and methods for the treatment of hemoglobinopathies
• Assessing nuclease cleavage
• CRISPR/Cas-related methods and compositions for treating Leber's congenital amaurosis 10 (LCA10)
+2 more — view all
KRMD KORU Medical Systems, Inc.9/122CF++11.2%$160.5M-0.7641827.1%Medical Devices
Score Breakdown
Patents: 1/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $46.3M
Cash: $7.4M
FCF: $-1.0M
ROE: -4.6% • D/E: 18%
Profit Margin: -1.8%
Quality
Low Debt FCF insufficient_data
Patents (2)
• Needle insertion device
• Needle insertion device
QUIK QuickLogic Corporation9/126CF++153.2%$175.8M3.335259.0%Semiconductors
Score Breakdown
Patents: 2/3 • Runway: 3/3 • Revenue: 3/3 • Mgmt: 1/3
Financials
Revenue: $19.4M
Cash: $19.2M
FCF: $5.8M
ROE: -32.3% • D/E: 25%
Profit Margin: -57.8%
Quality
FCF+ Low Debt FCF insufficient_data
Patents (6)
• Programmable logic device with design for test functionality
• Sectional configuration for programmable logic devices
• Programmable logic device with design for test functionality
+2 more — view all
Red Flags
SBC_HIGH (54% of revenue)
NNDM Nano Dimension Ltd.9/121572mo+18.7%$245.8M-5.34217.3%Computer Hardware
Score Breakdown
Patents: 3/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 1/3
Financials
Revenue: $125.9M
Cash: $395.4M
FCF: $-13.0M
ROE: -30.3% • D/E: 1%
Profit Margin: -118.4%
Quality
Low Debt FCF insufficient_data
Patents (15)
• Electromagnetic band gap element structure and fabrication methods
• Systems and methods for additive manufacturing passive resistor-capacitor frequency pass filter (PRC FPF)
• System and method for mimicking a neural network without access to the original training dataset or the target model
+2 more — view all
Red Flags
SBC_HIGH (66% of revenue)
ALLT Allot Ltd.9/123CF++15.3%$392.0M5.071635.1%Enterprise Software
Score Breakdown
Patents: 1/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $109.0M
Cash: $102.2M
FCF: $19.7M
ROE: 9.4% • D/E: 6%
Profit Margin: 9.4%
Quality
FCF+ Low Debt FCF insufficient_data
Patents (3)
• Method, system, and device of cellular traffic monitoring
• System, device, and method of protecting electronic devices against fraudulent and malicious activities
• System, method, and apparatus of securing and managing internet-connected devices and networks
LUNG Pulmonx Corporation9/121825mo+6.2%$124.6M-7.67716512.3%Medical Devices
Score Breakdown
Patents: 3/3 • Runway: 2/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $88.8M
Cash: $52.7M
FCF: $-9.5M
ROE: -90.3% • D/E: 165%
Profit Margin: -47.9%
Quality
FCF insufficient_data
Patents (18)
• Devices and systems for lung treatment
• Methods and systems for endobronchial diagnostics
• Methods, systems, and devices for analyzing lung imaging data
+2 more — view all
RELL Richardson Electronics, Ltd.9/127CF++18.9%$270.0M-0.63224.6%Electronic Components
Score Breakdown
Patents: 2/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 2/3
Financials
Revenue: $238.9M
Cash: $36.9M
FCF: $-1.5M
ROE: 5.2% • D/E: 2%
Profit Margin: 3.6%
Quality
Low Debt FCF insufficient_data
Patents (7)
• Hybrid capacitor energy storage
• Resistor
• Ultracapacitor generator start module
+2 more — view all
AIRG Airgain, Inc.9/121837mo+9.3%$52.5M-4.3431419.3%Communication Equipment
Score Breakdown
Patents: 3/3 • Runway: 2/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $52.7M
Cash: $7.7M
FCF: $-2.2M
ROE: -22.3% • D/E: 14%
Profit Margin: -12.6%
Quality
Low Debt FCF insufficient_data
Patents (18)
• Multi-band MIMO repeater system with carrier aggregation capability
• Antenna assembly for a vehicle
• Antenna assembly for a vehicle with sleep sense command
+2 more — view all
ARBE Arbe Robotics Ltd.9/12612mo+156.6%$56.3M-68.1-246416.1%Scientific Instruments
Score Breakdown
Patents: 2/3 • Runway: 1/3 • Revenue: 3/3 • Mgmt: 3/3
Financials
Revenue: $1.9M
Cash: $41.6M
FCF: $-38.4M
ROE: -83.2% • D/E: 64%
Profit Margin: N/A
Quality
FCF insufficient_data
Patents (6)
• Method for separating targets and clutter from noise, in radar signals
• Apparatus and method of two-stage signal processing in a radar system
• Apparatus and method of eliminating settling time delays in a radar system
+2 more — view all
UEIC Universal Electronics Inc.9/12135CF+-1.2%$88.4M21.6302022.5%Technology
Score Breakdown
Patents: 3/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $329.4M
Cash: $41.4M
FCF: $19.1M
ROE: -5.0% • D/E: 20%
Profit Margin: -2.2%
Quality
FCF+ Low Debt FCF insufficient_data
Patents (135)
• System and method for a self adaptive multi-user program guide
• Systems and methods for a customized media access user experience with privacy settings
• Controlling device configurable to enable selection of one or more services
+2 more — view all
YEXT Yext, Inc.9/1224CF+-1.8%$759.2M5.57562234.1%Enterprise Software
Score Breakdown
Patents: 3/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $443.0M
Cash: $86.8M
FCF: $41.9M
ROE: 27.8% • D/E: 622%
Profit Margin: 5.9%
Quality
FCF+ High ROE Wide Moat FCF insufficient_data
Patents (24)
• Electronic device display or portion thereof with a graphical user interface
• Online review generation using a redirection container
• Online merchant review system and method utilizing dynamic URL redirection for distributing review requests
+2 more — view all
EGHT 8x8 Inc9/12112CF++4.3%$337.0M22.6622284.8%Application Software
Score Breakdown
Patents: 3/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 2/3
Financials
Revenue: $752.5M
Cash: $101.7M
FCF: $76.0M
ROE: 5.1% • D/E: 228%
Profit Margin: 1.0%
Quality
FCF+ FCF insufficient_data
Patents (112)
• Server-based service configuration system and approach
• Management of VoIP device contact lists in a data communications services system
• Analysis of customer interaction metrics from digital voice data in a data-communication server system
+2 more — view all
AEYE AudioEye, Inc.9/125CF++7.2%$170.9M4.08032628.8%Application Software
Score Breakdown
Patents: 2/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $42.7M
Cash: $9.3M
FCF: $6.9M
ROE: -56.7% • D/E: 326%
Profit Margin: -7.1%
Quality
FCF+ FCF insufficient_data
Patents (5)
• Modular systems and methods for selectively enabling cloud-based assistive technologies
• Modular systems and methods for selectively enabling cloud-based assistive technologies
• Modular systems and methods for selectively enabling cloud-based assistive technologies
+2 more — view all
GEVO Gevo, Inc.9/126CF++94.2%$452.7M-3.853567.7%Basic Materials
Score Breakdown
Patents: 2/3 • Runway: 3/3 • Revenue: 3/3 • Mgmt: 1/3
Financials
Revenue: $217.8M
Cash: $67.6M
FCF: $-17.1M
ROE: -45.6% • D/E: 56%
Profit Margin: -83.7%
Quality
FCF insufficient_data
Patents (6)
• Selective formation of jet and diesel fuels from bio-based C3-C8 olefins via oligomerization with tungstated catalysts
• Simultaneous dehydration, dimerization, and metathesis of C2-C5 alcohols
• Upgrading of fusel oils over doped alumina
+2 more — view all
Red Flags
SBC_HIGH (98% of revenue)
CLPT ClearPoint Neuro Inc.9/121317mo+36.3%$271.8M-5.66127018.5%Medical Devices
Score Breakdown
Patents: 3/3 • Runway: 1/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $45.5M
Cash: $46.2M
FCF: $-15.3M
ROE: -167.5% • D/E: 270%
Profit Margin: -79.4%
Quality
FCF insufficient_data
Patents (13)
• Automatic, patient-specific targeting for deep brain stimulation
• Patient-specific infusion coverage estimates using segmented 3D brain representations
• Intrabody surgical fluid transfer assemblies with adjustable exposed cannula to needle tip length, related systems and methods
+2 more — view all
ELMD Electromed, Inc.9/121CF++10.6%$198.8M2.279017.6%Medical Devices
Score Breakdown
Patents: 1/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $75.6M
Cash: $15.9M
FCF: $4.4M
ROE: 24.5% • D/E: 0%
Profit Margin: 15.8%
Quality
FCF+ Low Debt High ROE Wide Moat Buffett FCF insufficient_data
Patents (1)
• Body pulsating apparatus and method
APYX Apyx Medical Corporation9/12733mo+22.1%$118.4M-8.16435727.6%Medical Devices
Score Breakdown
Patents: 2/3 • Runway: 2/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $58.4M
Cash: $27.6M
FCF: $-9.6M
ROE: -90.7% • D/E: 357%
Profit Margin: -14.8%
Quality
FCF insufficient_data
Patents (7)
• Devices, systems and methods for enhancing physiological effectiveness of medical cold plasma discharges
• Electrosurgical apparatus with dynamic leakage current compensation and dynamic RF modulation
• Skin status monitor and method thereof for electrosurgical apparatuses
+2 more — view all
AVXL Anavex Life Sciences Corp.9/121148mo-$86.5M-31.3--3.1%Biotech
Score Breakdown
Patents: 3/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 2/3
Financials
Revenue: $0.0M
Cash: $118.3M
FCF: $-27.1M
ROE: -12.8% • D/E: N/A
Profit Margin: N/A
Quality
FCF insufficient_data
Patents (11)
• A19-144, A2-73 and certain anticholinesterase inhibitor compositions and method for anti-seizure therapy
• Neurodevelopmental disorder therapy
• Enantiomers of A2-73, analogues, and sigma agonist activity
+2 more — view all
AUTL Autolus Therapeutics plc9/120CF++94.6%$311.4M--45144955.7%Biotech
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 3/3 • Mgmt: 3/3
Financials
Revenue: $137.4M
Cash: $248.4M
FCF: N/A
ROE: -174.9% • D/E: 1449%
Profit Margin: -186.4%
Quality
FCF insufficient_data
TMCI Treace Medical Concepts, Inc.9/125055mo-3.9%$345.5M-0.78012126.4%Medical Devices
Score Breakdown
Patents: 3/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $203.3M
Cash: $39.8M
FCF: $-2.4M
ROE: -74.0% • D/E: 121%
Profit Margin: -27.4%
Quality
FCF insufficient_data
Patents (50)
• Cut guide with integrated joint realignment features
• Contoured bone plate with locking screw for bone compression, particularly across a tarsometatarsal joint
• Bone positioning and preparing guide systems and methods
+2 more — view all
FDMT 4D Molecular Therapeutics, Inc.9/12422mo+4505.6%$689.5M-13.6-1681123.0%Biotech
Score Breakdown
Patents: 2/3 • Runway: 1/3 • Revenue: 3/3 • Mgmt: 3/3
Financials
Revenue: $96.1M
Cash: $307.0M
FCF: $-93.8M
ROE: -56.7% • D/E: 11%
Profit Margin: -208.6%
Quality
Low Debt FCF insufficient_data
Patents (4)
• Adeno-associated virus variant capsids and use for inhibiting angiogenesis
• Adeno-associated virus variant capsids and methods of use thereof
• Adeno-associated variants, formulations and methods for pulmonary delivery
+1 more — view all
OVID Ovid Therapeutics Inc.9/121228mo-$479.4M-7.2100616.9%Biotech
Score Breakdown
Patents: 3/3 • Runway: 2/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $1.5M
Cash: $136.6M
FCF: $-34.8M
ROE: -35.4% • D/E: 6%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
Patents (12)
• Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and related compounds, (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders
• Methods of treating developmental disorders with gaboxadol
• Use of (S)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and related compounds, (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders
+2 more — view all
XRX Xerox Holdings Corporation9/12554CF+-4.7%$125.5M317.631-12.5%Industrials
Score Breakdown
Patents: 3/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $7664.0M
Cash: $412.0M
FCF: $398.5M
ROE: -1673.8% • D/E: N/A
Profit Margin: -15.4%
Quality
FCF+ FCF insufficient_data
Patents (554)
• Characterizing meniscus behavior in 3D liquid metal printing
• Display screen with icon
• Printer jetting mechanism and printer employing the printer jetting mechanism
+2 more — view all
MASS 908 Devices Inc.8/120CF++35.3%$405.0M-4.453331.8%Medical Devices
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $65.8M
Cash: $99.1M
FCF: $-17.8M
ROE: -16.8% • D/E: 3%
Profit Margin: -36.9%
Quality
Low Debt FCF insufficient_data
PUBM PubMatic, Inc.8/120CF++17.1%$944.7M5.5661610.1%Application Software
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $300.8M
Cash: $144.5M
FCF: $52.3M
ROE: -0.6% • D/E: 16%
Profit Margin: -0.5%
Quality
FCF+ Low Debt FCF insufficient_data
OSPN OneSpan Inc.8/122CF++12.0%$823.1M4.87451.9%Enterprise Software
Score Breakdown
Patents: 1/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 2/3
Financials
Revenue: $253.2M
Cash: $51.4M
FCF: $39.4M
ROE: 26.8% • D/E: 5%
Profit Margin: 27.5%
Quality
FCF+ Low Debt High ROE Wide Moat Buffett FCF insufficient_data
Patents (2)
• Blockchain-enhanced proof of identity
• Blockchain-enhanced proof of identity
POWW Outdoor Holding Company8/120CF++22.1%$265.8M4.288516.4%Defense & Aerospace
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $53.7M
Cash: $68.8M
FCF: $11.2M
ROE: 2.0% • D/E: 5%
Profit Margin: 12.1%
Quality
FCF+ Low Debt FCF insufficient_data
CRNC Cerence Inc.8/121CF++11.8%$358.2M19.8791124.1%Application Software
Score Breakdown
Patents: 1/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 2/3
Financials
Revenue: $309.5M
Cash: $127.6M
FCF: $70.7M
ROE: -9.6% • D/E: 112%
Profit Margin: -5.0%
Quality
FCF+ FCF insufficient_data
Patents (1)
• Voice assistant error detection system
STXS Stereotaxis, Inc.8/120CF++19.6%$85.0M-523034.0%Medical Devices
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $31.5M
Cash: $4.0M
FCF: N/A
ROE: -117.4% • D/E: 30%
Profit Margin: -70.9%
Quality
Low Debt FCF insufficient_data
WEAV Weave Communications, Inc.8/120CF++15.5%$595.3M6.6726026.5%Health Tech
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $257.8M
Cash: $78.5M
FCF: $39.4M
ROE: -25.1% • D/E: 60%
Profit Margin: -8.0%
Quality
FCF+ FCF insufficient_data
CXDO Crexendo, Inc.8/120CF++43.9%$164.2M6.464731.2%Telecommunications
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $88.6M
Cash: $22.8M
FCF: $10.5M
ROE: 5.6% • D/E: 7%
Profit Margin: 4.5%
Quality
FCF+ Low Debt FCF insufficient_data
CODA Coda Octopus Group, Inc.8/123CF++9.2%$97.3M4.066144.8%Defense & Aerospace
Score Breakdown
Patents: 1/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $28.6M
Cash: $31.8M
FCF: $3.9M
ROE: 8.4% • D/E: 1%
Profit Margin: 17.6%
Quality
FCF+ Low Debt FCF insufficient_data
Patents (3)
• Technologies for dynamic, real-time, four-dimensional volumetric multi-object underwater scene segmentation
• Method of stabilizing sonar images
• Combined method of location of sonar detection device
GSIT GSI Technology, Inc.8/122933mo-6.6%$118.8M-12.8521015.0%Semiconductors
Score Breakdown
Patents: 3/3 • Runway: 2/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $24.7M
Cash: $69.2M
FCF: $-15.2M
ROE: -31.5% • D/E: 10%
Profit Margin: -79.5%
Quality
Low Debt FCF insufficient_data
Patents (29)
• In memory matrix multiplication and its usage in neural networks
• Reference distance similarity search
• Memory device for determining an extreme value
+2 more — view all
DUOT Duos Technologies Group, Inc.8/120CF++29.5%$158.1M-65.235020.1%Application Software
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $26.7M
Cash: $112.3M
FCF: $-103.1M
ROE: 36.0% • D/E: 0%
Profit Margin: 150.5%
Quality
Low Debt High ROE FCF insufficient_data
PRQR ProQR Therapeutics N.V.8/12029mo+120.4%$199.3M-9.61001935.3%Biotech
Score Breakdown
Patents: 0/3 • Runway: 2/3 • Revenue: 3/3 • Mgmt: 3/3
Financials
Revenue: $18.4M
Cash: $117.1M
FCF: $-19.1M
ROE: -57.4% • D/E: 19%
Profit Margin: -228.2%
Quality
Low Debt FCF insufficient_data
RMNI Rimini Street, Inc.8/121CF++8.3%$512.6M6.060-55.0%Application Software
Score Breakdown
Patents: 1/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $438.4M
Cash: $94.3M
FCF: $31.0M
ROE: N/A • D/E: N/A
Profit Margin: 2.5%
Quality
FCF+ FCF insufficient_data
Patents (1)
• Method and system for proactive client relationship analysis
CGEN Compugen Ltd.8/120CF++102.1%$198.9M-8630.2%Biotech
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 3/3 • Mgmt: 2/3
Financials
Revenue: $75.9M
Cash: $117.5M
FCF: N/A
ROE: 57.2% • D/E: 3%
Profit Margin: 47.9%
Quality
Low Debt High ROE Wide Moat FCF insufficient_data
FLGT Fulgent Genetics, Inc.8/121CF++7.5%$689.0M1.434138.7%Diagnostics
Score Breakdown
Patents: 1/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $330.3M
Cash: $292.7M
FCF: $9.7M
ROE: -8.7% • D/E: 1%
Profit Margin: -27.5%
Quality
FCF+ Low Debt FCF insufficient_data
Patents (1)
• Nanoparticles containing a taxane and their use
BKTI BK Technologies Corporation8/122CF++3.6%$231.9M2.251225.3%Communication Equipment
Score Breakdown
Patents: 1/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $91.5M
Cash: $29.2M
FCF: $5.2M
ROE: 28.6% • D/E: 2%
Profit Margin: 15.2%
Quality
FCF+ Low Debt High ROE Wide Moat Buffett FCF insufficient_data
Patents (2)
• System and method for managing access to a push-to-talk-over-cellular communication network
• System and method for managing access to a push-to-talk-over-cellular communication network
NNBR NN, Inc.8/120CF++26.2%$285.0M2.11415623.1%Industrials
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $483.0M
Cash: $12.3M
FCF: $5.9M
ROE: -17.5% • D/E: 156%
Profit Margin: -5.4%
Quality
FCF+ FCF insufficient_data
EOLS Evolus, Inc. Common Stock8/120189mo+13.0%$460.7M2.966-27.0%Pharma
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $325.5M
Cash: $41.7M
FCF: $13.4M
ROE: N/A • D/E: N/A
Profit Margin: -9.6%
Quality
FCF+ FCF insufficient_data
BCYC Bicycle Therapeutics plc8/12032mo+190.2%$236.2M-26.1-96384.7%Biotech
Score Breakdown
Patents: 0/3 • Runway: 2/3 • Revenue: 3/3 • Mgmt: 3/3
Financials
Revenue: $83.5M
Cash: $469.9M
FCF: $-61.7M
ROE: -25.2% • D/E: 3%
Profit Margin: -169.8%
Quality
Low Debt FCF insufficient_data
SEER Seer, Inc.8/128CF+-3.4%$87.6M-461027.7%Biotech
Score Breakdown
Patents: 2/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $14.1M
Cash: $155.9M
FCF: N/A
ROE: -26.2% • D/E: 10%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
Patents (8)
• Compositions, methods and systems for protein corona analysis and uses thereof
• Systems and methods for sample preparation, data generation, and protein corona analysis
• Compositions, methods and systems for protein corona analysis and uses thereof
+2 more — view all
IPHA Innate Pharma S.A.8/12163mo+16.5%$154.1M-18.8--38.3%Biotech
Score Breakdown
Patents: 3/3 • Runway: 0/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $9.8M
Cash: $10.9M
FCF: $-29.0M
ROE: N/A • D/E: N/A
Profit Margin: N/A
Quality
FCF insufficient_data
Patents (16)
• Variable regions for NKp46 binding proteins
• Treatment of peripheral T cell lymphoma
• NKp46 binding agents
+2 more — view all
ZVIA Zevia PBC8/120CF++18.4%$78.0M12.648130.9%Consumer Defensive
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $177.3M
Cash: $29.5M
FCF: $9.8M
ROE: -25.7% • D/E: 1%
Profit Margin: -4.8%
Quality
FCF+ Low Debt FCF insufficient_data
CURV Torrid Holdings Inc.8/125390mo-11.8%$226.4M9.734-73.9%Consumer Cyclical
Score Breakdown
Patents: 2/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $948.8M
Cash: $22.0M
FCF: $21.9M
ROE: N/A • D/E: N/A
Profit Margin: -0.9%
Quality
FCF+ FCF insufficient_data
Patents (5)
• Wire-free push-up brassiere with hinge for improved support and flexibility
• Power mesh panels for tummy-covering garments
• Wire-free push-up brassiere with hinge for improved support and flexibility
+2 more — view all
CURI CuriosityStream Inc.8/120CF++12.9%$185.7M16.760831.6%Communication Services
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $78.3M
Cash: $7.0M
FCF: $31.0M
ROE: 19.3% • D/E: 8%
Profit Margin: 11.0%
Quality
FCF+ Low Debt High ROE Wide Moat Buffett FCF insufficient_data
FBIO Fortress Biotech, Inc.8/120CF++14.0%$62.7M-27.3632636.9%Biotech
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $68.5M
Cash: $196.6M
FCF: $-17.1M
ROE: 116.0% • D/E: 26%
Profit Margin: 163.3%
Quality
Low Debt High ROE Wide Moat FCF insufficient_data
PERF Perfect Corp.8/121CF+-$202.7M2.780057.0%Application Software
Score Breakdown
Patents: 1/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $71.1M
Cash: $162.0M
FCF: $5.5M
ROE: 3.8% • D/E: 0%
Profit Margin: 8.1%
Quality
FCF+ Low Debt FCF insufficient_data
Patents (1)
• Blender including an integrated smart scale and a recipe application
SMC Summit Midstream Corporation8/120CF++24.6%$620.0M-5.84413477.7%Energy
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $620.4M
Cash: $12.5M
FCF: $-36.1M
ROE: -0.6% • D/E: 134%
Profit Margin: -0.6%
Quality
FCF insufficient_data
ELMT The Elmet Group Co.8/12028mo+55.6%$608.0M-31.9261267.0%Defense & Aerospace
Score Breakdown
Patents: 0/3 • Runway: 2/3 • Revenue: 3/3 • Mgmt: 3/3
Financials
Revenue: $257.0M
Cash: $112.3M
FCF: $-193.8M
ROE: 2.2% • D/E: 12%
Profit Margin: 1.5%
Quality
Low Debt FCF insufficient_data
RNGR Ranger Energy Services, Inc.8/120CF++26.3%$296.5M0.5181121.5%Energy Services
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $640.6M
Cash: $6.0M
FCF: $1.6M
ROE: 5.4% • D/E: 11%
Profit Margin: 2.4%
Quality
FCF+ Low Debt FCF insufficient_data
LAB Standard BioTools Inc.8/12486mo-0.9%$279.3M64.352552.4%Medical Devices
Score Breakdown
Patents: 2/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $84.4M
Cash: $461.1M
FCF: $179.6M
ROE: -7.8% • D/E: 5%
Profit Margin: 157.6%
Quality
FCF+ Low Debt FCF insufficient_data
Patents (4)
• Scientific instrument
• Parallelized sample processing and library prep
• Parallelized sample processing and library prep
+1 more — view all
SHIP Seanergy Maritime Holdings Corp8/120CF++22.3%$344.7M-7112327.5%Industrials
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $204.7M
Cash: $167.9M
FCF: N/A
ROE: 24.6% • D/E: 123%
Profit Margin: 36.3%
Quality
High ROE Wide Moat FCF insufficient_data
PROF Profound Medical Corp.7/12813mo+12.3%$271.8M-9.172153.1%Medical Devices
Score Breakdown
Patents: 2/3 • Runway: 1/3 • Revenue: 2/3 • Mgmt: 2/3
Financials
Revenue: $19.1M
Cash: $38.3M
FCF: $-24.8M
ROE: -73.5% • D/E: 15%
Profit Margin: -171.6%
Quality
Low Debt FCF insufficient_data
Patents (8)
• Multi-channel real-time phase modulation for EMI reduction in an ultrasound device
• System and method for open-loop ultrasound therapy to the prostate including restricting the therapy delivered to a predetermined angular range
• Ultrasonic therapy applicator and method of determining position of ultrasound transducers
+2 more — view all
EGAN eGain Corporation7/121CF+-7.0%$156.9M-73348.2%Application Software
Score Breakdown
Patents: 1/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $89.5M
Cash: $71.3M
FCF: N/A
ROE: 9.1% • D/E: 3%
Profit Margin: 8.5%
Quality
Low Debt FCF insufficient_data
Patents (1)
• System and method for automatic agent assistance based on real-time metrics
PSFE Paysafe Limited7/120CF++1.3%$210.2M82.05676953.0%Enterprise Software
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $1768.1M
Cash: $250.7M
FCF: $172.4M
ROE: -70.5% • D/E: 769%
Profit Margin: -20.8%
Quality
FCF+ FCF insufficient_data
PACB Pacific Biosciences of Californ7/125918mo+5.5%$612.0M7.228-1.9%Medical Devices
Score Breakdown
Patents: 3/3 • Runway: 1/3 • Revenue: 1/3 • Mgmt: 2/3
Financials
Revenue: $161.4M
Cash: $199.4M
FCF: $44.1M
ROE: N/A • D/E: N/A
Profit Margin: -81.3%
Quality
FCF+ FCF insufficient_data
Patents (59)
• Methods and compositions for sequencing double stranded nucleic acids
• Protected dye-labeled reagents
• High speed scanning system with acceleration tracking
+2 more — view all
LTBR Lightbridge Corporation7/120146mo-$158.9M-6.8--12.7%Electrical Equipment
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $0.0M
Cash: $236.7M
FCF: $-10.8M
ROE: -14.1% • D/E: N/A
Profit Margin: N/A
Quality
FCF insufficient_data
HYPR Hyperfine, Inc.7/12116mo+73.4%$66.7M-25.453444.9%Medical Devices
Score Breakdown
Patents: 1/3 • Runway: 1/3 • Revenue: 3/3 • Mgmt: 2/3
Financials
Revenue: $19.1M
Cash: $37.9M
FCF: $-17.0M
ROE: -101.7% • D/E: 44%
Profit Margin: -156.4%
Quality
Low Debt FCF insufficient_data
Patents (1)
• Suppressing image artifact with RF pulse phase in multi-shot SS-FSE sequence
AVNW Aviat Networks, Inc.7/122CF+-5.0%$224.1M4.3313410.9%Communication Equipment
Score Breakdown
Patents: 1/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $434.3M
Cash: $55.4M
FCF: $9.6M
ROE: -0.2% • D/E: 34%
Profit Margin: -0.1%
Quality
FCF+ Low Debt FCF insufficient_data
Patents (2)
• Resilient data communications with physical layer link aggregation, extended failure detection and load balancing
• Resilient data communications with physical layer link aggregation, extended failure detection and load balancing
TATT TAT Technologies Ltd.7/120CF++20.2%$488.7M-0.92780.5%Defense & Aerospace
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 2/3
Financials
Revenue: $196.2M
Cash: $53.7M
FCF: $-4.3M
ROE: 13.0% • D/E: 8%
Profit Margin: 12.2%
Quality
Low Debt FCF insufficient_data
WRAP Wrap Technologies, Inc.7/12136mo+102.8%$91.8M-4.864338.5%Scientific Instruments
Score Breakdown
Patents: 3/3 • Runway: 0/3 • Revenue: 3/3 • Mgmt: 1/3
Financials
Revenue: $6.1M
Cash: $4.8M
FCF: $-4.4M
ROE: -107.7% • D/E: 3%
Profit Margin: -223.1%
Quality
Low Debt FCF insufficient_data
Patents (13)
• Projectile cassette
• Systems and methods for generating optical beam arrays
• Projectile anchor
+2 more — view all
Red Flags
SBC_HIGH (91% of revenue)
SSTI SoundThinking, Inc.7/121CF+-0.4%$109.4M7.5501046.3%Application Software
Score Breakdown
Patents: 1/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $97.9M
Cash: $9.6M
FCF: $8.2M
ROE: -34.6% • D/E: 10%
Profit Margin: -23.5%
Quality
FCF+ Low Debt FCF insufficient_data
Patents (1)
• Systems and methods for weapon and destructive device detection based on electromagnetic field profile
OPAL OPAL Fuels Inc.7/122CF+-4.6%$212.4M-17.1318744.4%Industrials
Score Breakdown
Patents: 1/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $336.0M
Cash: $88.1M
FCF: $-36.4M
ROE: 8.9% • D/E: 87%
Profit Margin: 7.8%
Quality
FCF insufficient_data
Patents (2)
• Defuel priority panel
• Modular and portable compressed natural gas fueling station
BLZE Backblaze, Inc.7/120CF++25.5%$489.2M9.3633534.0%Enterprise Software
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 2/3
Financials
Revenue: $165.8M
Cash: $230.2M
FCF: $45.4M
ROE: -23.2% • D/E: 353%
Profit Margin: -11.5%
Quality
FCF+ FCF insufficient_data
RBBN Ribbon Communications Inc.7/12126mo+1.6%$263.4M3.05010548.4%Application Software
Score Breakdown
Patents: 1/3 • Runway: 2/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $801.0M
Cash: $40.4M
FCF: $8.0M
ROE: 5.0% • D/E: 105%
Profit Margin: 2.3%
Quality
FCF+ FCF insufficient_data
Patents (1)
• Telecommunication call emulation
SMWB Similarweb Ltd.7/120CF++8.8%$703.3M4.18020151.6%Application Software
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $295.6M
Cash: $73.9M
FCF: $29.1M
ROE: -94.0% • D/E: 201%
Profit Margin: -7.4%
Quality
FCF+ FCF insufficient_data
SIGA SIGA Technologies Inc.7/123121mo-49.7%$196.9M-5.923042.8%Pharma
Score Breakdown
Patents: 1/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $52.4M
Cash: $116.4M
FCF: $-11.7M
ROE: 0.4% • D/E: 0%
Profit Margin: 1.3%
Quality
Low Debt FCF insufficient_data
Patents (3)
• Polymorphic forms of ST-246 and methods of preparation
• ST-246 (tecovirimat monohydrate) suspension formulations
• Polymorphic forms of ST-246 and methods of preparation
GDYN Grid Dynamics Holdings, Inc.7/120CF++9.7%$1061.7M3.436331.2%IT Services
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $432.7M
Cash: $304.3M
FCF: $36.5M
ROE: 1.5% • D/E: 3%
Profit Margin: 1.8%
Quality
FCF+ Low Debt FCF insufficient_data
DERM Journey Medical Corporation7/12131mo+7.6%$122.2M-5.0667929.8%Pharma
Score Breakdown
Patents: 1/3 • Runway: 2/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $69.5M
Cash: $22.3M
FCF: $-6.1M
ROE: -17.6% • D/E: 79%
Profit Margin: -7.3%
Quality
FCF insufficient_data
Patents (1)
• Topical tetracycline compositions
ORMP Oramed Pharmaceuticals Inc.7/120204mo-$161.3M-0.2-028.3%Biotech
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $0.0M
Cash: $53.8M
FCF: $-0.4M
ROE: 53.5% • D/E: 0%
Profit Margin: N/A
Quality
Low Debt High ROE FCF insufficient_data
RPAY Repay Holdings Corporation7/120CF++97.4%$397.2M8.27016652.7%Enterprise Software
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 3/3 • Mgmt: 1/3
Financials
Revenue: $413.5M
Cash: $63.8M
FCF: $32.7M
ROE: -33.2% • D/E: 166%
Profit Margin: -41.2%
Quality
FCF+ FCF insufficient_data
Red Flags
SBC_HIGH (63% of revenue)
PMVP PMV Pharmaceuticals, Inc.7/12818mo-$95.9M-44.5-021.7%Biotech
Score Breakdown
Patents: 2/3 • Runway: 1/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $0.0M
Cash: $102.6M
FCF: $-42.7M
ROE: -99.4% • D/E: 0%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
Patents (8)
• Methods and compounds for restoring mutant p53 function
• Deuterated compounds for restoring mutant p53 function
• Methods and compounds for restoring mutant p53 function
+2 more — view all
PLBY Playboy, Inc.7/12058mo+9.4%$150.1M5.57266943.8%Consumer Cyclical
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $128.1M
Cash: $29.7M
FCF: $8.2M
ROE: 10.7% • D/E: 669%
Profit Margin: 1.3%
Quality
FCF+ FCF insufficient_data
MNOV MediciNova, Inc.7/12836mo+12.4%$71.5M-9.542012.8%Biotech
Score Breakdown
Patents: 2/3 • Runway: 2/3 • Revenue: 2/3 • Mgmt: 1/3
Financials
Revenue: $0.9M
Cash: $29.3M
FCF: $-6.8M
ROE: -24.8% • D/E: 0%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
Patents (8)
• Methods of treating post-COVID condition(s)
• Treatment of progressive neurodegenerative disease with ibudilast
• Methods of reducing plasma level of macrophage migratory inhibitory factor in patients
+2 more — view all
Red Flags
SBC_HIGH (80% of revenue)
XBIT XBiotech Inc.7/12332mo-$59.8M-47.7--38.8%Biotech
Score Breakdown
Patents: 1/3 • Runway: 2/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $0.0M
Cash: $109.5M
FCF: $-28.5M
ROE: -29.9% • D/E: N/A
Profit Margin: N/A
Quality
FCF insufficient_data
Patents (3)
• Arthritis treatment
• Compositions and methods for treating and preventing Staphylococcus aureus infections
• Treatment for neoplastic diseases
BRLT Brilliant Earth Group, Inc.7/122CF++2.3%$125.7M6.8575810.0%Consumer Cyclical
Score Breakdown
Patents: 1/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 2/3
Financials
Revenue: $451.8M
Cash: $76.2M
FCF: $8.6M
ROE: -8.6% • D/E: 58%
Profit Margin: -0.9%
Quality
FCF+ FCF insufficient_data
Patents (2)
• Ring
• Bracelet
ASUR Asure Software Inc7/120CF++10.4%$313.5M5.169368.5%Application Software
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 2/3
Financials
Revenue: $159.2M
Cash: $16.8M
FCF: $15.9M
ROE: -1.9% • D/E: 36%
Profit Margin: -2.3%
Quality
FCF+ Low Debt FCF insufficient_data
IIIN Insteel Industries, Inc.7/120CF++17.9%$540.0M3.51014.8%Industrials
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 2/3 • Mgmt: 2/3
Financials
Revenue: $739.5M
Cash: $37.5M
FCF: $19.1M
ROE: 7.9% • D/E: 1%
Profit Margin: 4.0%
Quality
FCF+ Low Debt FCF insufficient_data
ALTO Alto Ingredients, Inc.7/120CF++7.0%$283.9M1.162810.7%Basic Materials
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $960.2M
Cash: $23.6M
FCF: $3.0M
ROE: 20.5% • D/E: 28%
Profit Margin: 5.3%
Quality
FCF+ Low Debt High ROE Buffett FCF insufficient_data
NEXN Nexxen International Ltd.7/120CF++8.6%$587.7M12.082814.3%Communication Services
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $391.0M
Cash: $152.9M
FCF: $70.8M
ROE: 4.0% • D/E: 8%
Profit Margin: 4.9%
Quality
FCF+ Low Debt FCF insufficient_data
FATE Fate Therapeutics, Inc.6/121816mo-$155.7M-32.6-5611.8%Biotech
Score Breakdown
Patents: 3/3 • Runway: 1/3 • Revenue: 1/3 • Mgmt: 1/3
Financials
Revenue: $4.8M
Cash: $139.1M
FCF: $-50.7M
ROE: -67.8% • D/E: 56%
Profit Margin: N/A
Quality
FCF insufficient_data
Patents (18)
• Combining iPSC derived effector cell types for immunotherapy use
• Vial rack
• Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs
+2 more — view all
Red Flags
SBC_HIGH (399% of revenue)
AIRS AirSculpt Technologies, Inc.6/12092mo-8.7%$61.9M10.0666174.8%Healthcare
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $147.7M
Cash: $15.2M
FCF: $6.2M
ROE: -10.0% • D/E: 61%
Profit Margin: -6.4%
Quality
FCF+ FCF insufficient_data
SPWR SunPower Inc.6/12211mo-17.0%$52.3M7.452-71.5%Solar Energy
Score Breakdown
Patents: 3/3 • Runway: 0/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $283.1M
Cash: $4.1M
FCF: $3.9M
ROE: N/A • D/E: N/A
Profit Margin: -3.8%
Quality
FCF+ FCF insufficient_data
Patents (21)
• Water sealing surface attachment
• Systems and method for determining solar panel placement and energy output
• Methods of recycling silicon swarf into electronic grade polysilicon or metallurgical-grade silicon
+2 more — view all
HYSR SunHydrogen Inc.6/12072mo-$86.2M-4.4-01.1%Solar Energy
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 2/3
Financials
Revenue: $0.0M
Cash: $30.5M
FCF: $-3.8M
ROE: -22.9% • D/E: 0%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
AIOT PowerFleet, Inc.6/120CF++3.6%$327.9M7.355647.4%Application Software
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 2/3
Financials
Revenue: $454.5M
Cash: $26.8M
FCF: $24.0M
ROE: -4.3% • D/E: 64%
Profit Margin: -4.7%
Quality
FCF+ FCF insufficient_data
TTGT TechTarget, Inc.6/120CF+-2.5%$204.5M27.9582770.5%IT Services
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $482.1M
Cash: $35.3M
FCF: $57.1M
ROE: -22.1% • D/E: 27%
Profit Margin: -24.9%
Quality
FCF+ Low Debt FCF insufficient_data
DOMO Domo, Inc.6/120504mo-3.7%$167.0M6.575-16.0%Application Software
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $315.2M
Cash: $25.1M
FCF: $10.9M
ROE: N/A • D/E: N/A
Profit Margin: -13.4%
Quality
FCF+ FCF insufficient_data
XNET Xunlei Limited6/120CF+-1.4%$218.6M-50655.0%Enterprise Software
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $493.4M
Cash: $276.9M
FCF: N/A
ROE: -8.9% • D/E: 6%
Profit Margin: -14.5%
Quality
Low Debt FCF insufficient_data
NKTX Nkarta, Inc.6/12319mo-$85.2M-69.6-3315.3%Biotech
Score Breakdown
Patents: 1/3 • Runway: 1/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $0.0M
Cash: $156.6M
FCF: $-59.3M
ROE: -46.6% • D/E: 33%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
Patents (3)
• Immune cells comprising truncated NKG2D chimeric receptors
• Genetically modified natural killer cells for CD70-directed cancer immunotherapy
• CD19-directed chimeric antigen receptors and uses thereof in immunotherapy
RGNX REGENXBIO Inc.6/12620mo-69.2%$505.2M-25.5-6417013.3%Biotech
Score Breakdown
Patents: 2/3 • Runway: 1/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $153.9M
Cash: $251.0M
FCF: $-128.9M
ROE: -113.2% • D/E: 170%
Profit Margin: -113.9%
Quality
FCF insufficient_data
Patents (6)
• Anion exchange chromatography for recombinant AAV production
• Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS)
• Treatment of mucopolysaccharidosis IVA
+2 more — view all
INFU InfuSystems Holdings, Inc.6/120CF++3.0%$294.9M2.858375.6%Medical Devices
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 2/3
Financials
Revenue: $144.4M
Cash: $9.1M
FCF: $8.1M
ROE: 15.8% • D/E: 37%
Profit Margin: 6.5%
Quality
FCF+ Low Debt High ROE Wide Moat Buffett FCF insufficient_data
MBOT Microbot Medical Inc.6/12246mo-$65.7M-21.7-18510.0%Medical Devices
Score Breakdown
Patents: 1/3 • Runway: 2/3 • Revenue: 1/3 • Mgmt: 2/3
Financials
Revenue: $0.3M
Cash: $67.4M
FCF: $-14.2M
ROE: -32.9% • D/E: 1%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
Patents (2)
• Modular robotic system for driving movement of surgical tools
• Device for automatically inserting and manipulating a medical tool into and within a bodily lumen
RCEL Avita Medical, Inc.6/1216mo+53.1%$491.1M-1.782-1.5%Medical Devices
Score Breakdown
Patents: 1/3 • Runway: 0/3 • Revenue: 3/3 • Mgmt: 2/3
Financials
Revenue: $84.7M
Cash: $10.5M
FCF: $-8.4M
ROE: N/A • D/E: N/A
Profit Margin: -42.7%
Quality
FCF insufficient_data
Patents (1)
• Tissue processing tray
FULC Fulcrum Therapeutics, Inc.6/12257mo-$288.0M-14.3-216.8%Biotech
Score Breakdown
Patents: 1/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 1/3
Financials
Revenue: $0.0M
Cash: $306.5M
FCF: $-41.2M
ROE: -30.5% • D/E: 2%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
Patents (2)
• Compositions and methods for modulating FMR1 expression
• Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
Red Flags
HYPE_PRICING ($0.0M rev, $288M mcap)
OPRX OptimizeRx Corporation6/120CF+-29.8%$138.3M11.4731523.1%Health Tech
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $98.7M
Cash: $24.1M
FCF: $15.8M
ROE: 3.7% • D/E: 15%
Profit Margin: 4.7%
Quality
FCF+ Low Debt FCF insufficient_data
OKYO OKYO Pharma Limited6/12042mo-$70.8M-3.0--46.8%Biotech
Score Breakdown
Patents: 0/3 • Runway: 2/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $0.0M
Cash: $20.6M
FCF: $-2.1M
ROE: -263.8% • D/E: N/A
Profit Margin: N/A
Quality
FCF insufficient_data
STTK Shattuck Labs, Inc.6/12948mo-$473.6M-5.3-132.0%Biotech
Score Breakdown
Patents: 2/3 • Runway: 2/3 • Revenue: 1/3 • Mgmt: 1/3
Financials
Revenue: $0.0M
Cash: $196.3M
FCF: $-25.0M
ROE: -47.2% • D/E: 1%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
Patents (9)
• Heterodimeric proteins and uses thereof
• Fusion proteins for the treatment of cardiometabolic diseases
• Antibodies that bind TNFRSF25
+2 more — view all
Red Flags
HYPE_PRICING ($0.0M rev, $474M mcap)
BWEN Broadwind, Inc.6/120CF+-49.7%$56.1M12.5123313.0%Industrial Tech
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $148.9M
Cash: $16.2M
FCF: $7.0M
ROE: -0.3% • D/E: 33%
Profit Margin: -2.9%
Quality
FCF+ Low Debt FCF insufficient_data
VYGR Voyager Therapeutics, Inc.6/122312mo-70.0%$107.7M-63.6-2327.9%Biotech
Score Breakdown
Patents: 3/3 • Runway: 0/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $25.1M
Cash: $106.8M
FCF: $-68.5M
ROE: -58.9% • D/E: 23%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
Patents (23)
• Compositions and methods for delivery of AAV
• Redirection of tropism of AAV capsids
• Treatment of amyotrophic lateral sclerosis (ALS)
+2 more — view all
FATN FatPipe, Inc.6/12015mo+22.1%$65.3M-3.1901955.9%Enterprise Software
Score Breakdown
Patents: 0/3 • Runway: 1/3 • Revenue: 2/3 • Mgmt: 3/3
Financials
Revenue: $21.2M
Cash: $3.1M
FCF: $-2.0M
ROE: 27.5% • D/E: 19%
Profit Margin: 31.6%
Quality
Low Debt High ROE Wide Moat FCF insufficient_data
CAN Canaan Inc.6/12147mo-68.2%$115.5M-62.2-52418.9%Computer Hardware
Score Breakdown
Patents: 3/3 • Runway: 0/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $441.3M
Cash: $68.3M
FCF: $-71.8M
ROE: -97.1% • D/E: 24%
Profit Margin: -67.8%
Quality
Low Debt FCF insufficient_data
Patents (14)
• Cooling container for computing devices
• Modular computing apparatus with integrated power and signal routing
• Waste heat utilization system of immersed liquid cooling heat dissipation device
+2 more — view all
SELF Global Self Storage, Inc.6/120CF++0.6%$55.4M6.060348.2%Real Estate
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 2/3
Financials
Revenue: $12.8M
Cash: $7.5M
FCF: $3.3M
ROE: 4.5% • D/E: 34%
Profit Margin: 16.6%
Quality
FCF+ Low Debt FCF insufficient_data
HOVR New Horizon Aircraft Ltd.6/12039mo-$85.2M-17.7-018.3%Defense & Aerospace
Score Breakdown
Patents: 0/3 • Runway: 2/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $0.0M
Cash: $70.1M
FCF: $-15.1M
ROE: -66.9% • D/E: 0%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
GRVY GRAVITY Co., Ltd.6/120CF+-4.6%$492.0M-32059.3%Communication Services
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $562284.7M
Cash: $654692.0M
FCF: N/A
ROE: 13.2% • D/E: 0%
Profit Margin: 15.3%
Quality
Low Debt FCF insufficient_data
PNRG PrimeEnergy Resources Corporati6/120CF+-3.9%$308.7M7.865061.4%Energy
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $177.7M
Cash: $28.7M
FCF: $24.0M
ROE: 11.7% • D/E: 0%
Profit Margin: 14.0%
Quality
FCF+ Low Debt FCF insufficient_data
REA Rare Earths Americas, Inc.6/12040mo-$117.8M--053.8%Basic Materials
Score Breakdown
Patents: 0/3 • Runway: 2/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $0.0M
Cash: $68.3M
FCF: N/A
ROE: N/A • D/E: 0%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
GNE Genie Energy Ltd.6/120CF+-8.0%$481.6M6.528317.2%Utilities
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $491.5M
Cash: $215.2M
FCF: $31.3M
ROE: 14.7% • D/E: 3%
Profit Margin: 5.9%
Quality
FCF+ Low Debt FCF insufficient_data
IONR ioneer Ltd6/121115mo-$168.4M-100020.3%Basic Materials
Score Breakdown
Patents: 1/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 1/3
Financials
Revenue: $0.7M
Cash: $58.8M
FCF: N/A
ROE: N/A • D/E: 0%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
Patents (1)
• Apparatus and method for determining parameters of process operation
Red Flags
SBC_HIGH (305% of revenue)
NUCL Eagle Nuclear Energy Corp.6/12042mo-$110.4M-2.7-456.9%Nuclear Energy
Score Breakdown
Patents: 0/3 • Runway: 2/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $0.0M
Cash: $28.1M
FCF: $-3.0M
ROE: -250.8% • D/E: 4%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
RXST RxSight, Inc.5/122CF+-19.0%$223.1M17.676416.8%Medical Devices
Score Breakdown
Patents: 1/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 1/3
Financials
Revenue: $121.8M
Cash: $254.7M
FCF: $39.4M
ROE: -20.1% • D/E: 4%
Profit Margin: -43.8%
Quality
FCF+ Low Debt FCF insufficient_data
Patents (2)
• Light adjustable intraocular lens with a modulable absorption front protection layer
• Light adjustable intraocular lens with a modulable absorption front protection layer
Red Flags
SBC_HIGH (63% of revenue)
PERI Perion Network Ltd5/120CF+-4.6%$369.1M14.9344-11.9%Communication Services
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 2/3
Financials
Revenue: $436.2M
Cash: $267.8M
FCF: $55.1M
ROE: -2.0% • D/E: 4%
Profit Margin: -3.0%
Quality
FCF+ Low Debt FCF insufficient_data
ZNTL Zentalis Pharmaceuticals, Inc.5/12020mo-$167.1M-51.0-1820.2%Biotech
Score Breakdown
Patents: 0/3 • Runway: 1/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $0.0M
Cash: $228.9M
FCF: $-85.1M
ROE: -61.9% • D/E: 18%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
BLNK Blink Charging Co.5/12164mo-32.0%$61.0M27.63291.5%Industrials
Score Breakdown
Patents: 1/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 1/3
Financials
Revenue: $87.9M
Cash: $30.5M
FCF: $16.8M
ROE: -85.7% • D/E: 9%
Profit Margin: -64.9%
Quality
FCF+ Low Debt FCF insufficient_data
Patents (1)
• Self-aligning holster for J1772 plug used in electric vehicle supply equipment
Red Flags
SBC_HIGH (58% of revenue)
LRMR Larimar Therapeutics, Inc.5/12712mo-$313.7M-30.0-444.3%Biotech
Score Breakdown
Patents: 2/3 • Runway: 1/3 • Revenue: 1/3 • Mgmt: 1/3
Financials
Revenue: $0.0M
Cash: $156.3M
FCF: $-94.2M
ROE: -139.6% • D/E: 4%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
Patents (7)
• Methods for treating myelin associated diseases and mitochondria associated diseases
• Pharmaceutical composition comprising frataxin fusion protein and methods of use thereof
• Methods for quantifying frataxin activity
+2 more — view all
Red Flags
HYPE_PRICING ($0.0M rev, $314M mcap)
HUMA Humacyte, Inc.5/1249mo+36.5%$155.1M-36.2-3689.7%Biotech
Score Breakdown
Patents: 2/3 • Runway: 0/3 • Revenue: 2/3 • Mgmt: 1/3
Financials
Revenue: $2.4M
Cash: $64.5M
FCF: $-56.1M
ROE: -1423.6% • D/E: 368%
Profit Margin: N/A
Quality
FCF insufficient_data
Patents (4)
• Fluid systems, apparatuses, devices and methods of management thereof for cultivating tissue
• Tubular prostheses
• Drawer system for cultivating tissue
+1 more — view all
Red Flags
SBC_HIGH (268% of revenue)
PYPD PolyPid Ltd.5/1213mo-$132.2M-13.1-2941.2%Biotech
Score Breakdown
Patents: 1/3 • Runway: 0/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $0.0M
Cash: $6.6M
FCF: $-17.4M
ROE: -243.6% • D/E: 29%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
Patents (1)
• Compositions and methods for the treatment and prophylaxis of surgical site infections
ASRT Assertio Holdings, Inc.5/120121mo-62.5%$151.9M5.170533.1%Pharma
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 2/3
Financials
Revenue: $102.2M
Cash: $71.6M
FCF: $7.8M
ROE: -38.8% • D/E: 53%
Profit Margin: -34.9%
Quality
FCF+ FCF insufficient_data
CGTX Cognition Therapeutics, Inc.5/12024mo-$64.6M-36.1-28.0%Biotech
Score Breakdown
Patents: 0/3 • Runway: 2/3 • Revenue: 1/3 • Mgmt: 2/3
Financials
Revenue: $0.0M
Cash: $30.8M
FCF: $-23.3M
ROE: -48.6% • D/E: 2%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
CRBP Corbus Pharmaceuticals Holdings5/12015mo-$69.9M-71.3-525.5%Biotech
Score Breakdown
Patents: 0/3 • Runway: 1/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $0.0M
Cash: $115.3M
FCF: $-49.8M
ROE: -131.5% • D/E: 5%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
TNYA Tenaya Therapeutics, Inc.5/121015mo-$79.6M-37.410055.5%Biotech
Score Breakdown
Patents: 2/3 • Runway: 1/3 • Revenue: 1/3 • Mgmt: 1/3
Financials
Revenue: $3.0M
Cash: $66.8M
FCF: $-29.8M
ROE: -148.2% • D/E: 5%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
Patents (10)
• Gene therapy vectors for treating heart disease
• Cardiac cell reprogramming with myocardin and ASCL1
• Optimized expression cassettes for gene therapy
+2 more — view all
Red Flags
SBC_HIGH (1562% of revenue)
PRLD Prelude Therapeutics Incorporat5/12055mo-$275.3M-5.01001366.1%Biotech
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 1/3
Financials
Revenue: $22.4M
Cash: $151.8M
FCF: $-13.8M
ROE: -57.7% • D/E: 13%
Profit Margin: -269.7%
Quality
Low Debt FCF insufficient_data
Red Flags
SBC_HIGH (121% of revenue)
TLSA Tiziana Life Sciences Ltd5/1213mo-$72.5M-8.8--49.6%Biotech
Score Breakdown
Patents: 1/3 • Runway: 0/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $0.0M
Cash: $3.2M
FCF: $-6.4M
ROE: -780.6% • D/E: N/A
Profit Margin: N/A
Quality
FCF insufficient_data
Patents (1)
• Dactinomycin compositions and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemia
HNST The Honest Company, Inc.5/120CF+-8.6%$547.1M12.84239.7%Consumer Defensive
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 2/3
Financials
Revenue: $334.1M
Cash: $103.0M
FCF: $70.1M
ROE: 34.6% • D/E: 3%
Profit Margin: 23.5%
Quality
FCF+ Low Debt High ROE Wide Moat Buffett FCF insufficient_data
UPB Upstream Bio, Inc.5/12315mo-42.2%$152.4M-75.0100021.8%Biotech
Score Breakdown
Patents: 1/3 • Runway: 1/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $2.9M
Cash: $207.4M
FCF: $-114.3M
ROE: -53.5% • D/E: 0%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
Patents (3)
• Pharmaceutical composition comprising anti-human TSLP receptor antibody
• Pharmaceutical compositions comprising anti-human TSLP receptor antibodies and methods of using the same
• Pharmaceutical composition comprising anti-human TSLP receptor antibody
NPWR NET Power Inc.5/12023mo-$169.6M-46.4-147.1%Industrial Tech
Score Breakdown
Patents: 0/3 • Runway: 1/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $0.0M
Cash: $182.9M
FCF: $-78.6M
ROE: -69.8% • D/E: 1%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
SWMR Swarmer, Inc5/12021mo+56.6%$126.4M-49175.3%Enterprise Software
Score Breakdown
Patents: 0/3 • Runway: 1/3 • Revenue: 3/3 • Mgmt: 1/3
Financials
Revenue: $0.3M
Cash: $25.3M
FCF: N/A
ROE: N/A • D/E: 1%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
Red Flags
SBC_HIGH (1230% of revenue)
IPSC Century Therapeutics, Inc.4/12317mo-$299.6M-19.2-1844.1%Biotech
Score Breakdown
Patents: 1/3 • Runway: 1/3 • Revenue: 1/3 • Mgmt: 1/3
Financials
Revenue: $0.0M
Cash: $117.2M
FCF: $-57.5M
ROE: -51.2% • D/E: 18%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
Patents (3)
• Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
• Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
• Chimeric antigen receptor system with adaptable receptor specificity
Red Flags
HYPE_PRICING ($0.0M rev, $300M mcap)
VANI Vivani Medical, Inc.4/1209mo-$91.1M-18.5-9456.8%Biotech
Score Breakdown
Patents: 0/3 • Runway: 0/3 • Revenue: 1/3 • Mgmt: 3/3
Financials
Revenue: $0.0M
Cash: $19.9M
FCF: $-16.8M
ROE: -220.4% • D/E: 94%
Profit Margin: N/A
Quality
FCF insufficient_data
VUZI Vuzix Corporation4/12334mo-38.5%$114.5M-15.3-20222.7%Technology
Score Breakdown
Patents: 3/3 • Runway: 0/3 • Revenue: 0/3 • Mgmt: 1/3
Financials
Revenue: $5.5M
Cash: $9.2M
FCF: $-17.5M
ROE: -102.2% • D/E: 2%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
Patents (33)
• Wearable mobile electronic system
• Color correction for virtual images of near-eye displays
• Smart glasses
+2 more — view all
Red Flags
SBC_HIGH (135% of revenue)
INVZ Innoviz Technologies Ltd.4/122211mo-20.8%$51.9M-58.5-05610.3%Consumer Cyclical
Score Breakdown
Patents: 3/3 • Runway: 0/3 • Revenue: 0/3 • Mgmt: 1/3
Financials
Revenue: $50.0M
Cash: $54.4M
FCF: $-30.3M
ROE: -114.2% • D/E: 56%
Profit Margin: -171.2%
Quality
FCF insufficient_data
Patents (22)
• Systems and methods for photodiode-based detection
• Efficient optical transmission in LIDAR systems
• Distributing LIDAR system components
+2 more — view all
Red Flags
SBC_HIGH (56% of revenue)
VITL Vital Farms, Inc.4/12021mo-8.4%$389.4M-19.8246719.2%Consumer Defensive
Score Breakdown
Patents: 0/3 • Runway: 1/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $748.9M
Cash: $84.0M
FCF: $-77.0M
ROE: -7.4% • D/E: 67%
Profit Margin: -3.0%
Quality
FCF insufficient_data
CBUS Cibus, Inc.4/1213mo+30.1%$86.6M-57.6100-25.1%Biotech
Score Breakdown
Patents: 1/3 • Runway: 0/3 • Revenue: 2/3 • Mgmt: 1/3
Financials
Revenue: $4.5M
Cash: $10.7M
FCF: $-49.9M
ROE: -419.6% • D/E: N/A
Profit Margin: N/A
Quality
FCF insufficient_data
Patents (1)
• Plant shade
Red Flags
SBC_HIGH (1169% of revenue)
DAVA Endava plc4/120CF+-8.4%$77.2M40.12213812.1%Enterprise Software
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 0/3 • Mgmt: 1/3
Financials
Revenue: $727.6M
Cash: $48.4M
FCF: $30.9M
ROE: -99.8% • D/E: 138%
Profit Margin: -56.1%
Quality
FCF+ FCF insufficient_data
Red Flags
SBC_HIGH (61% of revenue)
ADUR Aduro Clean Technologies Inc.4/12080mo-$348.8M-2.3100129.2%Industrials
Score Breakdown
Patents: 0/3 • Runway: 3/3 • Revenue: 1/3 • Mgmt: 0/3
Financials
Revenue: $0.1M
Cash: $65.8M
FCF: $-8.0M
ROE: -48.3% • D/E: 1%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
Red Flags
SBC_HIGH (7738% of revenue) HYPE_PRICING ($0.1M rev, $349M mcap)
SES SES AI Corporation4/12028mo-6.7%$189.0M-20.21448.7%Consumer Cyclical
Score Breakdown
Patents: 0/3 • Runway: 2/3 • Revenue: 0/3 • Mgmt: 2/3
Financials
Revenue: $23.0M
Cash: $137.3M
FCF: $-38.2M
ROE: -30.6% • D/E: 4%
Profit Margin: -262.9%
Quality
Low Debt FCF insufficient_data
IRD Opus Genetics, Inc.4/12522mo-63.1%$384.7M-14.1-9312.5%Biotech
Score Breakdown
Patents: 2/3 • Runway: 1/3 • Revenue: 0/3 • Mgmt: 1/3
Financials
Revenue: $7.9M
Cash: $89.0M
FCF: $-54.4M
ROE: -615.6% • D/E: 93%
Profit Margin: N/A
Quality
FCF insufficient_data
Patents (5)
• Salts and esters of APX3330 and therapeutic uses thereof
• Methods and compositions for treatment of mydriasis
• Aqueous ophthalmic solutions of phentolamine and medical uses thereof
+2 more — view all
Red Flags
SBC_HIGH (1113% of revenue)
RCKT Rocket Pharmaceuticals, Inc.3/12020mo-$256.8M38.6-1720.1%Biotech
Score Breakdown
Patents: 0/3 • Runway: 1/3 • Revenue: 1/3 • Mgmt: 1/3
Financials
Revenue: $0.0M
Cash: $269.5M
FCF: $99.1M
ROE: -5.0% • D/E: 17%
Profit Margin: N/A
Quality
FCF+ Low Debt FCF insufficient_data
Red Flags
HYPE_PRICING ($0.0M rev, $257M mcap)
CRDF Cardiff Oncology, Inc.3/12310mo-14.1%$56.5M-43.0-23.1%Biotech
Score Breakdown
Patents: 1/3 • Runway: 0/3 • Revenue: 0/3 • Mgmt: 2/3
Financials
Revenue: $0.5M
Cash: $34.5M
FCF: $-24.3M
ROE: -94.1% • D/E: 2%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
Patents (3)
• PLK1 inhibitor in combination with anti-angiogenics for treating metastatic cancer
• PLK1 inhibitor in combination with anti-angiogenics for treating metastatic cancer
• Cancer treatment using FGFR inhibitors and PLK1 inhibitors
DMAC DiaMedica Therapeutics Inc.3/12012mo-$474.3M-4.0-053.1%Biotech
Score Breakdown
Patents: 0/3 • Runway: 1/3 • Revenue: 1/3 • Mgmt: 1/3
Financials
Revenue: $0.0M
Cash: $34.9M
FCF: $-19.0M
ROE: -100.2% • D/E: 0%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
Red Flags
HYPE_PRICING ($0.0M rev, $474M mcap)
NINE Nine Energy Service, Inc.3/1208mo-3.7%$103.5M-3.41410034.8%Energy Services
Score Breakdown
Patents: 0/3 • Runway: 0/3 • Revenue: 0/3 • Mgmt: 3/3
Financials
Revenue: $536.0M
Cash: $16.8M
FCF: $-3.6M
ROE: 283.8% • D/E: 100%
Profit Margin: 12.7%
Quality
High ROE FCF insufficient_data
SUPX SuperX AI Technology Limited3/12016mo-$223.1M-48.1-5228.2%Enterprise Software
Score Breakdown
Patents: 0/3 • Runway: 1/3 • Revenue: 1/3 • Mgmt: 1/3
Financials
Revenue: $20.3M
Cash: $98.9M
FCF: $-107.3M
ROE: -103.8% • D/E: 2%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
Red Flags
SBC_HIGH (167% of revenue)
BTQ BTQ Technologies Corp.3/1215mo-$210.3M-1.4-635.0%Enterprise Software
Score Breakdown
Patents: 1/3 • Runway: 0/3 • Revenue: 1/3 • Mgmt: 1/3
Financials
Revenue: $0.0M
Cash: $9.8M
FCF: $-3.0M
ROE: -489.2% • D/E: 6%
Profit Margin: N/A
Quality
Low Debt FCF insufficient_data
Patents (1)
• Non-volatile storage of secure data in 6T SRAM cells using hot carrier injection
Red Flags
HYPE_PRICING ($0.0M rev, $210M mcap)
GALT Galectin Therapeutics Inc.2/12010mo-$307.6M-4.8--52.6%Biotech
Score Breakdown
Patents: 0/3 • Runway: 0/3 • Revenue: 1/3 • Mgmt: 1/3
Financials
Revenue: $0.0M
Cash: $13.3M
FCF: $-14.9M
ROE: N/A • D/E: N/A
Profit Margin: N/A
Quality
FCF insufficient_data
Red Flags
HYPE_PRICING ($0.0M rev, $308M mcap)
VIVO VivoPower PLC2/1200mo-$71.3M54.52419039.9%Enterprise Software
Score Breakdown
Patents: 0/3 • Runway: 0/3 • Revenue: 1/3 • Mgmt: 1/3
Financials
Revenue: $2.5M
Cash: $0.1M
FCF: $38.9M
ROE: -185.9% • D/E: 190%
Profit Margin: N/A
Quality
FCF+ FCF insufficient_data
Red Flags
SBC_HIGH (1837% of revenue)
GCTS GCT Semiconductor Holding, Inc.1/12010mo-17.9%$116.2M-23.1-38-11.6%Semiconductors
Score Breakdown
Patents: 0/3 • Runway: 0/3 • Revenue: 0/3 • Mgmt: 1/3
Financials
Revenue: $4.1M
Cash: $30.2M
FCF: $-26.9M
ROE: N/A • D/E: N/A
Profit Margin: N/A
Quality
FCF insufficient_data
Red Flags
SBC_HIGH (369% of revenue)
30 stocks auto-rejected (red flags)
EVTL reverse_split
ARQQ reverse_split
SPCE reverse_split
VELO reverse_split
KULR reverse_split
ALIT reverse_split
SENS reverse_split
NRXP reverse_split
AGEN reverse_split
DTIL reverse_split
GOSS reverse_split
RIGL reverse_split
LYEL reverse_split
MNPR reverse_split
MYPS reverse_split
SABS reverse_split
BNED reverse_split
XFOR reverse_split
COOK reverse_split
DPRO reverse_split
YSG reverse_split
GDEV reverse_split
SRZN reverse_split
IBIO reverse_split
TNXP reverse_split
DVLT reverse_split
NGNE reverse_split
ASMB reverse_split
GRRR reverse_split
SIDU reverse_split

Disclaimer: Micro cap stocks are inherently risky. This screener identifies innovation signals — it is not a buy recommendation. Always do your own due diligence. See our 7-step risk assessment methodology and full disclaimer.